Pacira | PCRX - 股本和储备



金融业
股票价格
USD
资产
USD 1.24B
现金及等价物
USD 205.88M
销售成本
USD 58.49M
流动资产
USD 615.22M
流动负债
USD 122.01M
债务
USD 363.12M
EBIT
USD 9.96M
EBITDA
USD 48.67M
员工
790
EPS每股收益
USD 0.73
股本和储备
USD 671.98M
销售毛利
USD 133.91M
债务利息支出
USD 3.62M
利息收入
USD 1.93M
贷款资金
USD 363.12M
市值
USD 1.19B
净收入
USD 4.65M
营业费用
USD 180.54M
营业利润
USD 9.96M
普通股股本
USD 39.82M
PE价格收益
35.68
税前利润
USD 5M
销售收入
USD 192.4M
销售和管理费用
USD 91.81M
股票
USD 134.58M
贸易债权人
USD 17.51M
应收帐款人
USD 132.42M


股本和储备 更改 日
Astellas Pharma JPY 1.94T 113.64B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Cara Therapeutics USD 14.5M 6.44M 2026-03
Coherus Biosciences USD 60.84M 17.78M 2026-06
Heron Therapeutics USD 9.14M 4.15M 2026-03
Ironwood Pharmaceuticals USD -217.14M 44.69M 2026-03
J&J USD 84.97B 3.78B 2026-06
Ligand Pharmaceuticals USD 967.52M 29.81M 2026-06
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Novo Nordisk DKK 221.28B 18.21B 2026-06
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 671.98M 18.08M 2026-06
Perrigo USD 2.52B 17M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Teva Pharmaceutical Industries USD 7.75B 475M 2026-06
Xeris Pharmaceuticals USD -9.73M 22.74M 2026-06
Zoetis USD 3.15B 85M 2026-06